Tag: TALTZ
Positive results for Taltz in COAST-X trial
Results from the COAST-X trial show that patients treated with Taltz (ixekizumab, Eli Lilly and Company) achieved improvement in the signs and symptoms of...
Positive top-line results for second phase 3 study of Taltz in...
The results of the COAST-W trial demonstrate that Taltz (ixekizumab; Eli Lilly and Company) is a safe and effective treatment for Ankylosing Spondylitis (AS),...